RNWL
INTERNATIONAL REGISTRATION RENEWED
17/07/2025
Voltar para busca
Dado oficial do USPTO
CAPITALBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
18/07/2025
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10, 42
Data de depósito
03/08/2005
Data de registro
09/09/2008
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/09/2018
Última transação
18/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
16
Localização do titular
Beijing, CN
Examinador
BOULTON,KELLY F
Unidade examinadora
L20
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
C. C. (pessoa física)
C. C. (pessoa física)
C. C. (pessoa física)
Representantes
Sarah L. Bruno Arent Fox LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Surface active chemical agents for use in the manufacture of slidesbeads and particles; anti-animalcule preparations used in food and medicine to prevent micro-organisms; chemical preparations for scientific applications; chemical reagents for research purposes; chemical reagents for use in scientific apparatus for chemical or biological analysisphosphate bufferpolyethylene glycol (PEG)dextransilane reagents for surface treatment; chemical preparations used for analysis in laboratoriesnamely solvents for use in the separationisolation and purification of biologically active substances in bacteriological culturesnamely DMSOethanolglycerol; chemical preparations for scientific analyses in laboratories; cryogenic preparations for preservation of biological products; diagnostic preparations other than for medical or veterinary applications; reagent papers for scientific research; chemical test papers; biological preparations for scientific and laboratory research;bacteriological preparations for use in food manufacture and cosmetic manufacture other than for medical and veterinary applications; media cultures of microorganisms for use in scientific research and testing and not for medical and veterinary applications; bacteriological preparations to create acidification in laboratory research
Classe 5
Solvents for dissolving bacteriological cultures for laboratory use; bacterial preparations for medical and veterinary applications; chemical-pharmaceutical preparations for use in medical diagnosis and medical diagnostic testing; nutritive substances for microorganism cultures; culture medium of bacteriological microorganisms for medical and veterinary applications; biological preparations for medical applications; chemical preparations for pharmaceutical applications; diagnostic preparations for medical applications; chemical preparations for medical or veterinary applications; preparations for trace elements for human and animal use as dietary food supplements; semen for artificial fertilization; soil disinfectants; chemical preparations for medical applications
Classe 9
Laboratory incubators for bacteria culture; chromatography apparatus for laboratorial applications; diagnostic apparatus for determining the content of veterinary drug residues in food samples; apparatus for physical chemical testingplant metabolite analyzer and profiler apparatus; apparatus and instruments for measuringtesting and analyzing physical and chemical ingredients for laboratory use; apparatus and instruments for measuring physical properties of matter and energy; apparatus and instruments for measuring and testing chemical and biochemical compositionsstructuresproperties and reactions for laboratory use in scientific research; apparatus and instruments for non-medical detection and analysis of manufacturing techniques in the composition of biochips made from organic molecules; non-medical diagnostic apparatus and instruments for use in the application of medical biochip manufacturing techniques
Classe 10
Incubators for medical applications; medical instrumentsmicro array biochip scanners for testinganalyzingevaluating biological samples for medical applications; analysis instruments for medical treatment applicationsautomated and semi-automated chemiluminescent immunoassay analyzerautomated biochemical analyzerautomated nucleic acid extractor; diagnostic apparatus for medical applicationsreal-time PCR machineliquid handling machine; apparatus for diagnosing human genetic diseaseinfection diseasecardiac diseasetumordiabetesby the application of biochip techniques; medical apparatus and instruments for detection and analysis of human genetic disease or infection diseasecardiac diseasetumordiabetesby the application of biochip technique
Classe 42
Research and development of new products for others; technical research in the fields of molecular typingprotomicssystem biologygeneticsgenomic medicinemolecular medicinehealth carediagnosticsbiosafetyforensic scienceconducting high-throughput technique services in multi-field including nucleic acidproteincelltissuewhile employing microarray platforms; conducting technical project studies in the field of molecular typingprotomicsgeneticsgenomic medicinemolecular medicinehealth carediagnosticsbiosafetyforensic scienceconducting high-throughput technique services in the multi-field including nucleic acidproteincelltissuewhile employing microarray platforms; chemical analyses; chemical laboratory servicessynthesissurface chemistryreagents; chemical research; bacteriological research; biological research; rental of scientific laboratory apparatus for use in biochip research; rental of laboratory apparatus and instruments for detection and analysis of medical conditions and diseases by the application of biochip technique; providing medical diagnostic services by the application of biochip technique; quality control for others; providing quality assurance services by evaluating research controls and detecting area for improvement
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
13/09/2018
71AG
REGISTERED-SEC.71 ACCEPTED
13/09/2018
ES71
TEAS SECTION 71 RECEIVED
06/09/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/09/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
20/08/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/04/2015
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
17/05/2014
71AG
REGISTERED-SEC.71 ACCEPTED
17/05/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/05/2014
71AF
REGISTERED-SEC.71 FILED
12/05/2014
ES71
TEAS SECTION 71 RECEIVED
12/05/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/03/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/03/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/12/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/01/2009
FIMP
FINAL DISPOSITION PROCESSED
06/01/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/12/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
09/09/2008
PUBO
PUBLISHED FOR OPPOSITION
24/06/2008
NPUB
NOTICE OF PUBLICATION
04/06/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/05/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/05/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
18/04/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2008
ALIE
ASSIGNED TO LIE
18/04/2008
PAPER RECEIVED
16/04/2008
CHLD
CHANGE OF OWNER RECEIVED FROM IB
14/12/2007
CNRT
NON-FINAL ACTION MAILED
21/11/2007
CNRT
NON-FINAL ACTION WRITTEN
21/11/2007
UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
28/06/2007
CNRT
NON-FINAL ACTION MAILED
24/05/2007
CNRT
NON-FINAL ACTION WRITTEN
24/05/2007
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
17/05/2007
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/05/2007
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/05/2007
UNDN
UNDELIVERABLE MAIL - NO ACTION TAKEN
05/12/2006
CNRT
NON-FINAL ACTION MAILED
26/10/2006
CNRT
NON-FINAL ACTION WRITTEN
25/10/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/10/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2006
PAPER RECEIVED
11/09/2006
RFNT
REFUSAL PROCESSED BY IB
30/03/2006
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/03/2006
RFRR
REFUSAL PROCESSED BY MPU
08/03/2006
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/03/2006
CNRT
NON-FINAL ACTION WRITTEN
03/03/2006
DOCK
ASSIGNED TO EXAMINER
22/02/2006
NWAP
NEW APPLICATION ENTERED
02/12/2005
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/12/2005
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CAPITALBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.